Canada’s Ophthalmology Therapeutics market size stood at around USD XX.X billion in 2019 and is projected to reach USD XX billion by 2028, exhibiting a CAGR of around 2% during the forecast period.
The Canada Ophthalmology Devices Market is expected to grow with a CAGR of 2% during the forecasted period, this market growth attributes due to the prevalence of diabetes and glaucoma in the region. Increasing incidence of vision impairment, advancements in technology in the field of medicine & growing geriatric population across the country along the increase in disposable income of the people are some of the factors adding up to the industry growth. Also growing awareness among the masses for regular check-ups for early detection of eye disorders is leading the market growth.
Market Driving Factors
In Canada, an increasing number of people suffering from diabetes and glaucoma, increasing incidence of vision impairment, Technological innovation, the rising geriatric population, and increased investments in the development of combination therapies are the major factors driving the growth of this market. With the growing prevalence of eye diseases and the related increase in disability-adjusted life years (DALYs), the demand for the accurate treatment of diseases is expected to rise in the coming years. This, in turn, will increase the demand for ophthalmic devices in Canada.